FDA recall record

Bao Gong Da Ginseng recall — FDA F-1543-2013

The firm initiated this recall of "American Ginseng" because FDA lab analysis found pesticide residues.

Class IIIclassification
F-1543-2013official record ID
Jun 26, 2013report date

Recall record at a glance

Official recordF-1543-2013
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmBao Gong Da Inc.
Report dateJun 26, 2013
Recall initiation dateMay 10, 2013
Quantity2,422 lbs
LocationPico Rivera, CA, United States

Official product description

Ginseng. American Ginseng, 4 oz. and 8 oz. retail packages and bulk ginseng in 20, 30, or 40 lbs. in a clear plastic bag. Bulk products are not labeled.

Why the product was recalled

The firm initiated this recall of "American Ginseng" because FDA lab analysis found pesticide residues.

Distribution information

US States: CA, TX, NV, NY.

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.